Skip to content

Author

Xiaohan Ying

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

CHST1 Drives Immunotherapy Resistance in Triple‐Negative Breast Cancer by Orchestrating an Immunosuppressive Microenvironment via the NKRF–CCL20–Macrophage Axis

Mechanical analyses support a CHST1–NKRF–CCL20 regulatory model and identifies CCR6 blockade as a potential therapeutic strategy and a CHST1–NKRF–CCL20 expression signature showed potential value for stratifying immunotherapy response.

Shu-hao Jiang, Xiao-Han Ying, Ruoqing Wang et al. · 0 citations
Review Open access Jul 2026

Tumor evolution: signaling pathways, molecular mechanisms and therapeutic targets

The models and drivers of tumor evolution are discussed, focusing on how cancer cells adapt and evolve under multidimensional selective pressure, including the intracellular, extracellular, and exogenous levels.

Kun-Yu Zhang, Xiu-Zhi Zhu, Yuxin Yan et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.